Alpha-Cell to Beta-Cell Communication: A New Twist on the Incretin Effect |
10/30/2020 - 12:00pm to 1:00pm CDT |
Approach to a Patient with Non-diabetic Hypoglycemia |
11/13/2020 - 12:00pm to 1:00pm CST |
Bone Quality in Obese Women with Type 2 Diabetes/RADIANT: A Look at Atypical Diabetes |
09/18/2020 - 12:00pm to 1:00pm CDT |
Clinical Outcomes in Immune Checkpoint Inhibitor-Induced Diabetes Mellitus/A Hemoglobin A1c Level of 7% Is the Threshold for Bone Impairment in Men with Type 2 Diabetes Mellitus |
04/23/2021 - 12:00pm to 1:00pm CDT |
Driving Atypical Diabetes |
09/04/2020 - 12:00pm to 1:00pm CDT |
Glucagon Revisited: Glycemic and Energetic Effects of Glucagon Receptor Agonism |
03/26/2021 - 12:00pm to 1:00pm CDT |
Glucose-Lowering Medications and Cardiovascular Disease: Searching for the Holy Grail |
01/15/2021 - 12:00pm to 1:00pm CST |
Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes/Predictors of Glycemic Success in Sensor-Augmented Insulin Pump therapy: A Retrospective Review of Patients at the Michael E DeBakey VA Medical Center |
10/09/2020 - 12:00pm to 1:00pm CDT |
Incretin-Based Therapies: How Do They Work? |
02/12/2021 - 12:00pm to 1:00pm CST |
Macrophages under Pressure: Novel Roles in Hypertension |
02/26/2021 - 12:00pm to 1:00pm CST |